AAAAI & ACAAI GUIDELINES Bundle (free trial)

Anaphylaxis 2016

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/636525

Contents of this Issue

Navigation

Page 24 of 27

25 Table 15. World Health Organization Diagnostic Criteria for Cutaneous and Systemic Mastocytosis Cutaneous mastocytosis Typical clinical findings of urticaria pigmentosa or maculopapular cutaneous mastocytosis, diffuse cutaneous mastocytosis, or solitary mastocytoma and typical infiltrates of mast cells in a multifocal or diffuse pattern at skin biopsy examination Systemic mastocytosis Diagnosis of systemic mastocytosis is made if 1 major criterion and 1 minor criterion are present or if 3 minor criteria are met Major criterion Multifocal, dense infiltrates of mast cells (≥15 in aggregates) detected in sections of bone marrow and/or another extracutaneous organ and confirmed by tryptase immunohistochemistry or other special stains Minor criteria A In biopsy sections of bone marrow or other extracutaneous organs, >25% of mast cells in the infiltrate are spindle-shaped or have atypical morpholog y; or, of all mast cells in bone marrow aspirates smears, >25% are immature or atypical mast cells B Detection of activating point mutation at codon 816 of KIT in bone marrow, blood, or another extracutaneous organ C Mast cells in bone marrow, blood, or another extracutaneous organ express CD117 with CD2 and/or CD25 D Serum total tryptase persistently >20 ng/mL in the absence of associated clonal myeloid disorder

Articles in this issue

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Anaphylaxis 2016